Health CanadaGeneral Alert
Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA
Published: September 10, 2018Recall ID: 58118Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA
Recalling Firm: Communications and Public Affairs Branch
Reason for Recall / Hazard
New safety information
Product Description & Identification
Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA
Additional Source Details
| Field | Value |
|---|---|
| N I D | 58118 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/health-canada-updates-canadians-estimates-health-risks-recalled-valsartan-drugs |
| Issue | New safety information |
| Title | Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2018-09-10 |
| Organization | Communications and Public Affairs Branch |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmCommunications and Public Affairs Branch
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Communications and Public Affairs Branch - Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA Check if your household is affected: https://therecallfile.com/recalls/health-canada-updates-canadians-on-estimates-of-health-risks-for-recal/CANADA-58118
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordHealth Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA